Gevo, Inc. s trend and data analysis indicates that the stock price has dropped -71.67% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -89.42% . Looking at the past 52 week period, the stock price is down -86.54% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Gevo, Inc. has a negative value of -41.2 compared to overall market performance.Based on the Stock Research the Relative Strength Index signal is in over sold territory with a range of 28.82.
Stocks of Gevo, Inc. (NASDAQ:GEVO) rallied by 3.03% during the past week but lost 21.54% on a 4-week basis. The company has outperformed the S&P 500 by 2.79% in the past week but underperformed the index by 22.43% in the last 4 weeks.
For the current week, the company shares have a recommendation consensus of Buy. Gevo, Inc. (NASDAQ:GEVO) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.03 points or 2.86% at $1.02 with 1,492,346 shares getting traded. Post opening the session at $1.05, the shares hit an intraday low of $0.97 and an intraday high of $1.0599 and the price was in this range throughout the day. The company has a market cap of $15 million and the number of outstanding shares has been calculated to be 14,910,334 shares. The 52-week high of Gevo, Inc. (NASDAQ:GEVO) is $27.2 and the 52-week low is $0.92.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Company shares were Reiterated by Rodman & Renshaw on Jan 13, 2017 to Buy, Raises Price Target to $ 12 from a previous price target of $4 .
Company has reported several Insider transactions to the SEC, on Mar 15, 2017, Patrick R. Gruber (Chief Executive Officer) sold 6 shares at 0.96 per share price.On Mar 15, 2017, Christopher Michael Ryan (President and COO) sold 7 shares at 0.96 per share price.On Mar 15, 2017, Gregory Roda (Chief Commercial Officer) sold 1 shares at 0.96 per share price.
Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels.